Categories: EHRNeurologyNews

Hop on a Cure Makes Financial Contribution Toward Massachusetts General Hospital’s Sean M. Healey & AMG Center for ALS

BOSTON, MA / ACCESSWIRE / April 24, 2024 / Hop On A Cure, a leading advocate in the fight against ALS, has announced today their financial contribution of $250,000 toward Massachusetts General Hospital Department of Neurology’s Sean M. Healey & AMG Center for ALS.

Hop On A Cure Logo
Official blue and white logo for Hop On A Cure

The gift will support the research project Exploring the Effect of Statins to Restore Stathmin-2 Function and Promote Motor Neuron Regeneration, which is conducted by Matthew Nolan PhD, an early career investigator mentored by Clotilde Lagier-Tourenne, MD, PhD, the Araminta Broch-Healey Endowed Chair in ALS. Dr. Lagier-Tourenne and her collaborators have discovered that normal stathmin-2 (STMN2) function is critical to motor neuron health and outgrowth. Thus, loss of STMN2 appears to contribute to the muscle weakness characterizing ALS. The team has found that in cell models, normalizing STMN2 using gene-targeted therapies helps to rescue motor neurons, which potentially could restore function in people with ALS.

“We at Hop On A Cure are thrilled to support this innovative and accessible potential new therapy,” said Hop On A Cure CEO Nic Shefrin. “We are also excited to champion promising young talent, like Dr. Nolan, who have committed themselves to ALS research.”

“The work that we do at the Healey & AMG Center would not be possible without the support of foundations like Hop On A Cure,” said Dr. Lagier-Tourenne. “My team and I are grateful, and excited to be able to move forward with this research that will benefit the lives of people with ALS and their families.”

In addition to the contribution to Mass General, Hop On A Cure is also helping spread awareness and raise money for this year’s Boston College ALS Awareness Game at Fenway Park on Thursday, April 25. The game, now in its fifth year, has been played annually in honor of former Boston College baseball captain and Ice Bucket Challenge founder Pete Frates, who passed away from ALS in 2019 at the age of 34. Hop On A Cure has donated a signed Zac Brown Band guitar, which will be auctioned off to raise additional money for the cause.

Hop On A Cure was founded in 2022 by John Driskell Hopkins (Hop), and his wife Jennifer, following his diagnosis with ALS (commonly known as Lou Gehrig’s Disease) in 2021. Hopkins is a multi-GRAMMY® Award-winning founding member and songwriter of Zac Brown Band. With this rare platform in mind, Hop On A Cure was established to increase ALS awareness and to raise funds to enable new research to find ways to treat this disease, which currently has no known cure.

For more information about Hop On A Cure, visit their website.

For more information about the Healey & AMG Center for ALS, click here.

Contact Information

Elise Anderson
Owner, Elicity Public Relations
elise@elicitypr.com
(615) 946-6055

SOURCE: Hop On A Cure

View the original press release on newswire.com.

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

53 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

53 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

4 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

5 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

19 hours ago